Bill to eliminate third-party pharmacy benefit managers could save state millions
Fox 25 Oklahoma – January 24, 2020
By Destiny Washington
OKLAHOMA CITY (KOKH) — Oklahoma could soon join the growing number of states backing away from using Pharmacy Benefit Managers (PBM’s) to administer prescription-drug programs.
A PBM is a third-party administrator of prescription drug programs for state and federal government employee plans, self-insured employer plans, commercial health plans, and Medicare Part D plans.
Sen. Paul Scott (R-Duncan) filed Senate Bill 1901 to replace the state’s third-party PBM’s with a direct-to-pharmacy payment system – a move he said could save the state millions and help significantly lower prescription drug prices for state employees.
“Drug costs are skyrocketing, and Oklahomans need help. No one should have to choose between their prescriptions and eating or paying utility bills but that has become the norm for many. It’s time we cut out the middleman and get our citizens the savings they desperately need.” Scott said.
SB 1901 would direct the Oklahoma Employees Insurance and Benefits Board to collaborate with the Oklahoma Health Care Authority (OHCA) to make the change.
By July 1, 2021, the two entities would establish pricing to lower prescription drug prices for all enrollees of any health insurance plans offered under the Oklahoma Employee Insurance and Benefits Act.
Scott said OHCA is already doing this for SoonerCare recipients and his proposal would allow them to do the same for all state employees.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.